VITALE, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.623
AS - Asia 3.977
EU - Europa 3.423
SA - Sud America 670
AF - Africa 126
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.514
SG - Singapore 1.509
IT - Italia 1.041
CN - Cina 1.023
HK - Hong Kong 949
BR - Brasile 602
DE - Germania 499
FI - Finlandia 436
PL - Polonia 263
VN - Vietnam 258
SE - Svezia 199
FR - Francia 194
UA - Ucraina 181
GB - Regno Unito 162
RU - Federazione Russa 140
NL - Olanda 96
IN - India 64
AT - Austria 57
CA - Canada 47
IE - Irlanda 35
BD - Bangladesh 24
MX - Messico 22
ZA - Sudafrica 21
JP - Giappone 20
AR - Argentina 19
CI - Costa d'Avorio 19
AL - Albania 14
SA - Arabia Saudita 13
TR - Turchia 13
UZ - Uzbekistan 13
BE - Belgio 12
VE - Venezuela 12
CZ - Repubblica Ceca 10
ES - Italia 10
IQ - Iraq 10
PH - Filippine 10
CH - Svizzera 9
CL - Cile 9
EG - Egitto 9
EC - Ecuador 8
GR - Grecia 8
MA - Marocco 8
AU - Australia 7
JO - Giordania 7
PK - Pakistan 7
MD - Moldavia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
BB - Barbados 5
BZ - Belize 5
IL - Israele 5
MG - Madagascar 5
PA - Panama 5
PG - Papua Nuova Guinea 5
RO - Romania 5
SC - Seychelles 5
UY - Uruguay 5
AM - Armenia 4
BG - Bulgaria 4
CO - Colombia 4
CY - Cipro 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
TH - Thailandia 4
TN - Tunisia 4
TW - Taiwan 4
YT - Mayotte 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
EU - Europa 3
KR - Corea 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LU - Lussemburgo 3
ML - Mali 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UG - Uganda 3
AD - Andorra 2
AO - Angola 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
GM - Gambi 2
Totale 26.781
Salva come PNG Salva come JPEG
Città #
Fairfield 3.076
Woodbridge 1.864
Houston 1.451
Chandler 1.368
Ashburn 1.275
Ann Arbor 1.204
Seattle 1.178
Cambridge 982
Wilmington 977
Hong Kong 945
Singapore 812
Jacksonville 525
San Diego 384
Boardman 382
Santa Clara 359
Princeton 332
Des Moines 262
Dong Ket 244
Bytom 239
Medford 214
Helsinki 207
Beijing 202
Roxbury 182
Padova 177
Munich 171
Nanjing 137
Guangzhou 83
Shenyang 72
Nanchang 48
New York 47
Nuremberg 46
Hebei 45
Los Angeles 43
Dearborn 41
Rome 41
Milan 38
São Paulo 38
Jiaxing 36
London 35
Dublin 33
Shanghai 32
Turku 32
Changsha 31
Falls Church 31
Jinan 31
Tianjin 29
Chicago 26
Falkenstein 26
Norwalk 22
Venice 22
Warsaw 22
Las Vegas 20
Redwood City 20
Treviso 20
Abidjan 19
Ogden 18
Padua 16
Vienna 16
Brasília 15
Hangzhou 15
Tokyo 15
Belo Horizonte 14
Ningbo 14
Pune 14
San Francisco 14
Frankfurt am Main 13
Indiana 13
Kharkiv 13
Paris 13
Tashkent 13
Bologna 12
Buffalo 12
Zhengzhou 12
Curitiba 11
Dallas 11
Rio de Janeiro 11
Amsterdam 10
Detroit 10
Dhaka 10
Hanover 10
Kilburn 10
San Jose 10
Taizhou 10
Tirana 10
Toronto 10
Villafranca Padovana 10
Atlanta 9
Cagliari 9
Düsseldorf 9
Florence 9
Guarulhos 9
Johannesburg 9
Kunming 9
Lappeenranta 9
Lauterbourg 9
Modena 9
Ottawa 9
Pomezia 9
Vicenza 9
Washington 9
Totale 20.689
Salva come PNG Salva come JPEG
Nome #
Salvataggio d’organo attraverso emitrasposizione porto-cavale in trombosi porto-spleno- meseraica acuta dopo OLTx
G. 253
Termoablazione con microonde nel trattamento della recidiva locale di epatocarcinoma dopo trapianto ortotopico di fegato.
 191
Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy 183
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma 180
Alcohol abuse and de novo tumors in liver transplantation 177
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 175
Use of N-acetylcysteine during liver procurement: A prospective randomized controlled study. 173
When to perform hepatic resection for intermediate-stage hepatocellular carcinoma 171
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 168
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 163
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 163
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 161
Prospective validation of the Barcelona Clinic Liver Cancer staging system 159
Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. 158
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 156
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 155
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 154
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 154
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 152
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 150
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 146
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation 146
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 146
The survival benefit of liver transplantation in hepatocellular carcinoma patients 143
Reply: The easiest way to improve the outcome of suboptimal liver grafts 143
Liver radiofrequency ablation as emergency treatment for a ruptured hepatocellular carcinoma: a case report 143
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 142
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 141
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 141
The two faces of hepatocellular carcinoma prognostic evaluation: 'observational' or 'pragmatic' approach? 141
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 139
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 138
146 EARLY INTRODUCTION OF EVEROLIMUS IN DE NOVO LIVER TRANSPLANTATION: A MULTICENTER RANDOMIZED CLINICAL TRIAL (EPOCAL) 138
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? 137
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 137
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 137
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 137
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 137
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report 136
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 136
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis 135
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC 135
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. 135
Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration 134
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 134
LAPAROSCOPIC ABLATION AND SALVAGE TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 134
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 133
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 133
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 132
Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures 132
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 132
Meld-na and Survival Benefit In Liver Transplantation 131
TRAPIANTO DI FEGATO PER EPATOCOLANGIOCARCINOMA INCIDENTALE: ESPERIENZA DI CENTRO 130
Erratum to "A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list" [J Hepatol 2013;60:290-297]. 130
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 129
EXTREME MARGINAL DONOR: SEVERE HYPOTHERMIA AS A RARE PRESERVATION CONDITION FOR EXPLANTABLE ORGANS - A CASE REPORT 128
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 128
Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma 128
Monofocal hepatocellular carcinoma: How much does size matter? 128
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 127
Liver transplantation for the management of hepatoblastoma 126
The survival benefit of laparoscopic ablation over trans-arterial chemoembolization in patients with hepatocellular carcinoma ineligible for liver resection or percutaneous ablation 126
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection 125
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 125
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 125
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. 123
Alcohol- and substance-dependent subjects: The correlated factors in qualifying for liver transplantation 123
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation 123
Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score 122
Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study 121
Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation 120
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 120
Early Introduction of Everolimus in De Novo Liver Transplantation: A Multicenter Randomized Clinical Trial (EPOCAL). 119
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation 119
Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case Report 119
Risk Factors for Early Mortality in Liver Transplant Patients 119
Combined liver and kidney transplantation: analysis of Padova experience. 118
Sorafenib use in the transplant setting. 118
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 118
The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma 118
Neoadjuvant Therapy Protocol and Liver Transplantation in Combination With Pancreatoduodenectomy for the Treatment of Hilar Cholangiocarcinoma Occurring in a Case of Primary Sclerosing Cholangitis: Case Report With a More Than 8-Year Disease-Free Survival 116
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma 116
THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA 115
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 115
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 115
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 115
Liver autotransplantation for the treatment of unresectable hepatic metastasis: an uncommon indication-a case report. 115
Intensive Care Unit Admission of Decompensated Cirrhotic Patients: Prognostic Scoring Systems 114
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 114
Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis 114
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 113
A Novel Model of Priority Assessment For Patients With and Without Hepatocellular Carcinoma On A Common Liver Transplant Waiting List: A Multicentre, Cohort Study 113
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 112
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 112
Multimodal therapy before liver transplantation for hepatocellular carcinoma. 112
Early surgery for the treatment of toxic megacolon 111
Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure ? 111
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 111
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 111
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 111
Totale 13.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.723
article - articoli 82.062
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 352
Totale 182.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.423 181 273 148 315 107 233 217 307 433 353 368 488
2021/20224.434 115 476 437 248 135 218 1.117 197 136 58 555 742
2022/20232.783 555 269 132 320 408 413 35 162 303 28 115 43
2023/20241.514 114 233 144 119 92 110 131 66 54 113 159 179
2024/20256.144 11 348 295 202 787 198 262 464 501 255 1.089 1.732
2025/2026174 174 0 0 0 0 0 0 0 0 0 0 0
Totale 27.155